These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Contribution to the therapy of otomycosis]. Albano V Ann Laringol Otol Rinol Faringol; 1966; 65(4):521-9. PubMed ID: 6014495 [No Abstract] [Full Text] [Related]
43. Medical practice and limitations of ear drops. Patil BB J Indian Med Assoc; 1983 Oct; 81(7-8):127-8. PubMed ID: 6676363 [No Abstract] [Full Text] [Related]
44. [Clinico-microbiological assessment of therapeutic antifungal drugs therapeutic activity in patients with atopic dermatitis sensitized to yeast fungi]. Mokronosova MA; Samuĭlova TL; Arzumanian VG; Sveranovskaia VV; Gervazieva VB Ter Arkh; 1999; 71(11):37-41. PubMed ID: 10626333 [TBL] [Abstract][Full Text] [Related]
45. [Contribution to the therapy of otomycosis]. Beck C Z Laryngol Rhinol Otol; 1969 Feb; 48(2):119-23. PubMed ID: 5780953 [No Abstract] [Full Text] [Related]
46. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients. Li L; Wang Z; Li R; Luo S; Sun X Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669 [TBL] [Abstract][Full Text] [Related]
47. Simultaneous bilateral fungal keratitis caused by different fungi. Prajna NV; Rao RA; Mathen MM; Prajna L; George C; Srinivasan M Indian J Ophthalmol; 2002 Sep; 50(3):213-4. PubMed ID: 12355697 [TBL] [Abstract][Full Text] [Related]
48. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect. Varis T; Kivistö KT; Backman JT; Neuvonen PJ Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751 [TBL] [Abstract][Full Text] [Related]
49. [Therapeutic value of a new local antifungal-antibiotic-corticoid in eczematoid dermo-epidermitis]. Temime P; Oddoze L; Temime M Therapeutique; 1969; 45(6):82-4. PubMed ID: 5398596 [No Abstract] [Full Text] [Related]
50. A novel controlled local drug delivery system for inner ear disease. Paulson DP; Abuzeid W; Jiang H; Oe T; O'Malley BW; Li D Laryngoscope; 2008 Apr; 118(4):706-11. PubMed ID: 18182968 [TBL] [Abstract][Full Text] [Related]
51. [Fungal keratitis--diagnostic and therapeutic approach]. Niţulescu C Oftalmologia; 2006; 50(4):33-8. PubMed ID: 17345800 [TBL] [Abstract][Full Text] [Related]
52. Dexamethasone phosphate in antibiotic ear drops for the treatment of acute bacterial otitis externa. Mösges R; Schröder T; Baues CM; Sahin K Curr Med Res Opin; 2008 Aug; 24(8):2339-47. PubMed ID: 18606053 [TBL] [Abstract][Full Text] [Related]
53. Ear drops. Woolf SM Can Med Assoc J; 1972 Jun; 106(12):1287. PubMed ID: 5035133 [No Abstract] [Full Text] [Related]
54. Dose-related prolongation of tetracaine spinal anesthesia by oral clonidine in humans. Ota K; Namiki A; Iwasaki H; Takahashi I Anesth Analg; 1994 Dec; 79(6):1121-5. PubMed ID: 7978436 [TBL] [Abstract][Full Text] [Related]
55. [Scopulariopsis brevicaulis otomycosis after tympanoplasty]. Hennequin C; el-Bez M; Trotoux J; Simonet M Ann Otolaryngol Chir Cervicofac; 1994; 111(6):353-4. PubMed ID: 7785936 [TBL] [Abstract][Full Text] [Related]
56. Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature. Wall GM; Stroman DW; Roland PS; Dohar J Pediatr Infect Dis J; 2009 Feb; 28(2):141-4. PubMed ID: 19116600 [TBL] [Abstract][Full Text] [Related]